| Literature DB >> 36229640 |
Patrick Reinbacher1, Maria Anna Smolle2, Joerg Friesenbichler1, Alexander Draschl1, Andreas Leithner1, Werner Maurer-Ertl1.
Abstract
Cementless calcar-guided femoral short stems in total hip arthroplasty (THA) have become increasingly popular over the years. Early distal migration of femoral stems measured by Einzel-Bild-Roentgen Analyse, Femoral Component Analyse (EBRA-FCA) has been reported to be a risk factor for aseptic loosening. The aim of this study was to analyse axial migration behavior and subsidence of a new short stem (launched in 2015) over a follow-up period of 3 years. According to the study protocol, 100 hip osteoarthritis patients who consecutively received an unilateral cementless calcar-guided short stem (ANA.NOVA proxy) at a single department were prospectively included in this mid-term follow-up study. Thirteen patients were lost to follow-up, resulting in 87 patients with unilateral THA who fulfilled the criteria for migration analysis with EBRA-FCA. The cohort comprised 41 males (mean age: 60 ± 16.5; mean BMI (Body Mass Index): 30 ± 13) and 46 females (mean age: 61 ± 15.5; mean BMI: 27 ± 10). Seven standardized radiographs per patient were analyzed with EBRA-FCA. An average migration of 2.0 mm (0.95-3.35) was observed within the first 3 years. The median increase during the first year was higher than in the second and third year (1.2 mm [IQR: 0.5-2.15] vs. 0.3 mm [IQR: 0.1-0.6 mm] vs. 0.25 mm [IQR: 0.1-0.5 mm]. Detected migration did not lead to stem loosening, instability, dislocation, or revision surgery in any patient. A higher risk for subsidence was observed in male and heavyweight patients, whereas the female gender was associated with a lower risk. No correlation between migration and revision could be observed. Although moderate subsidence was detectable, the performance of the short stem ANA.NOVA proxy is encouraging. Yet, its use may be re-considered in overweight and male patients due to more pronounced subsidence.Entities:
Mesh:
Year: 2022 PMID: 36229640 PMCID: PMC9561653 DOI: 10.1038/s41598-022-22160-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Flow-chart of the study cohort.
Figure 2EBRA-FCA.
Figure 3(a) Horizontal distance between the center of the prosthetic head and the shoulder point, (b) Vertical distance between the center of the prosthetic head and the shoulder point, (c) Distance between the shoulder point and the tip of the prosthesis, from R. Biedermann et al. J Bone Joint Surg Br 1999[13].
Patient characteristics of the study cohort (n = 87).
| Age at surgery (in years; mean ± SD) | 60.9 ± 7.8 |
| Male | 41 (47.1%) |
| Female | 46 (52.9%) |
| BMI (median; IQR) | 28.9 [25.2; 31.2] |
| Left | 43 (49.4%) |
| Right | 44 (50.6%) |
| Length of hospital stay (in days; median; IQR) | 7 [6; 8] |
| A | 23 (26.4%) |
| B | 57 (65.5%) |
| C | 7 (8.1%) |
| 1 | 10 (11.9%) |
| 2 | 54 (64.3%) |
| 3 | 18 (21.4%) |
| 4 | 2 (2.4%) |
| 32 mm | 5 (5.8%) |
| 36 mm | 82 (94.2%) |
| Cup size (median; IQR) | 54 [52; 56] |
| Shaft size (median; IQR) | 6 [5; 7] |
| 6 weeks | 0.25 [0.05; 0.9] |
| Increase (in mm; median; IQR) | + 0.2 [0.1; 0.5] |
| 3 months | 0.55 [0.2; 1.25] |
| Increase (in mm; median; IQR) | + 0.25 [0.1; 0.5] |
| 6 months | 0.9 [0.4; 1.8] |
| Increase (in mm; median; IQR) | + 0.25 [0.1; 0.5] |
| 12 months | 1.2 [0.5; 2.15] |
| Increase (in mm; median; IQR) | + 0.3 [0.1; 0.6] |
| 24 months | 1.55 [0.7; 2.75] |
| Increase (in mm; median; IQR) | + 0.25 [0.1; 0.5] |
| 36 months | 2.0 [0.95; 3.35] |
SD Standard deviation, BMI Body mass index, IQR Interquartile range.
Figure 4Distribution of cup and shaft sizes of the study cohort.
Figure 5Average subsidence of the study cohort over time.
Figure 6Average subsidence of the study cohort over time separated by gender (red = female; blue = male).
Multivariate random effects model on the course of subsidence.
| b | (SE) | z | 95% Conf. interval | ||
|---|---|---|---|---|---|
| Time (month) | 0.05 | 0.00 | 19.3 | < | 0.05; 0.06 |
| Age at surgery | 0.01 | 0.02 | 0.46 | 0.644 | − 0.03; 0.04 |
| BMI | 0.04 | 0.03 | 1.45 | 0.148 | − 0.02; 0.10 |
| Gender (female) | − 0.55 | 0.28 | − 1.99 | − 1.08; − 0.01 | |
| Constant | − 0.78 | 1.36 | − 0.57 | 0.568 | − 3.45; 1.89 |
Significant values are in [bold].
BMI Body mass index, SE Standard error.